Search all medical codes

Injection, dexrazoxane hydrochloride, per 250 mg

HCPCS code

Name of the Procedure:

Injection, dexrazoxane hydrochloride, per 250 mg
Common Name(s): Dexrazoxane Injection
Technical/Medical Term: Intravenous Injection of Dexrazoxane Hydrochloride

Summary

Dexrazoxane injection is a medical procedure where a medication called dexrazoxane hydrochloride is administered through an IV injection. This drug is used as a protective agent to reduce the risk of heart damage in patients undergoing certain types of chemotherapy.

Purpose

Medical Conditions Addressed:

  • Cardioprotection during chemotherapy, especially with medications like doxorubicin that are known to cause heart damage.

    Goals/Expected Outcomes:

  • To minimize or prevent cardiac toxicity in patients receiving high doses of anthracycline chemotherapy drugs like doxorubicin.

Indications

Specific Symptoms/Conditions:

  • Patients undergoing anthracycline chemotherapy who are at increased risk of cardiac complications.

Patient Criteria:

  • Typically prescribed for cancer patients receiving high cumulative doses of anthracyclines.

    Preparation

    Pre-Procedure Instructions:

  • No special fasting is required, but follow any specific guidelines provided by your healthcare provider.
  • Medication adjustments may be necessary; inform your healthcare provider about all current medications.

Required Assessments:

  • Baseline cardiac function tests (e.g., echocardiogram).
  • Blood tests to monitor kidney and liver function.

Procedure Description

Step-by-Step Explanation:

  1. The patient will be seated or lying down.
  2. An IV line will be placed into a vein, typically in the arm.
  3. Dexrazoxane hydrochloride will be administered slowly through the IV line.
  4. The healthcare provider will monitor the patient for any immediate reactions.

Tools/Equipment:

  • IV setup, including a catheter and infusion pump.

Anesthesia or Sedation:

  • Not typically required.

Duration

The injection process usually takes about 15-30 minutes.

Setting

The procedure is typically performed in a hospital oncology unit or an outpatient chemotherapy clinic.

Personnel

  • Oncologist or oncology nurse
  • Possibly a pharmacist for preparation of the medication

Risks and Complications

Common Risks:

  • Mild pain or discomfort at the injection site

Rare Risks:

  • Allergic reactions
  • Nausea or vomiting
  • Changes in blood counts

Possible Complications:

  • Monitor for signs of allergic reactions or other adverse effects, and manage them promptly with medications as necessary.

Benefits

Expected Benefits:

  • Significant reduction in the risk of heart damage due to chemotherapy.

Timeline for Benefits:

  • Protective effects are immediate, offering cardiac protection concurrent with chemotherapy treatment.

Recovery

Post-Procedure Care:

  • Patients can resume normal activities almost immediately after the procedure.

Expected Recovery Time:

  • No significant recovery time needed; minimal to no side effects.

Restrictions or Follow-Up:

  • Follow-up appointments to monitor cardiac function and overall health during cancer treatment.

Alternatives

Other Treatment Options:

  • Dose adjustment or alternative chemotherapy regimens that are less cardiotoxic.
  • Use of other cardioprotective drugs.

Pros and Cons:

  • Dexrazoxane is specifically effective for preventing heart damage, which alternative chemotherapy adjustments might not fully address.

Patient Experience

During the Procedure:

  • Patients might feel a mild prick when the IV is inserted and mild discomfort during the injection.

After the Procedure:

  • Some may experience minor side effects like nausea, but these are generally manageable.
  • Pain management or anti-nausea medications may be provided for comfort.

Similar Codes